Biotechnology, one of molecular biology’s branches, monitored and intentional manipulation of biological organisms, processes or systems to effectively make or process drugs, or any other products and substances useful to enhancing people’s living quality. The earliest examples of humans applying their knowledge of biotechnology involved the efforts to enhance plants and animals’ species by cross-pollination (allogamy) or cross-breeding.
Biotechnology has recently turned to a more sophisticated business, considerably enlarged in scale and application range. Having goodly restored from the recession, the world Biotechnology Market is anticipated to be eventually estimated at far over EUR 245 billion by end-2015. However, with the numerous benefits this advanced technology comes laden with, there are worries about its potential misuse. Concerns over this issue has trailed into some attempting to facilitate the enforcement of specific laws constraining or even banning relevant programs and research (e.g. human cloning).
The research reports from this Catalogue offer a comprehensive outlook on the worldwide Biotechnology Market. The reports identify major market challenging forces and growth drivers, provide fresh statistics on the Biotechnology Industry, outline various trends and factors specifying the market’s direction, and more. Regional and country markets’ reviews are at hand in the reports too. Furthermore, companies with their innovations are discussed, and also short to long term forecasts are provided in the researches.
Publications found:
1,388
Sort by:
Asia Pacific Stem Cell Therapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, and Other Stem Cell Therapy), Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Hospitals & Specialty Clinics and Academic & Research Institutes)
US$ 3,000.00
The Asia Pacific stem cell therapy market was valued at US$ 403.94 million in 2022 and is projected to reach US$ 1,180.20 million by 2028; it is expected to grow at a CAGR of 19.6% from 2022 to 2028....
May 2023
141 pages
Europe Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)
US$ 3,000.00
The Europe blood plasma derivatives market was valued at US$ 8,474.00 million in 2022 and is projected to reach US$ 14,262.27 million by 2028; it is expected to grow at a CAGR of 9.1% from 2022 to 202...
May 2023
158 pages
Europe Stem Cell Therapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, and Other Stem Cell Therapy), Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Hospitals & Specialty Clinics and Academic & Research Institutes)
US$ 3,000.00
The Europe stem cell therapy market was valued at US$ 446.75 million in 2022 and is projected to reach US$ 1,209.01 million by 2028; it is expected to grow at a CAGR of 18.0% from 2022 to 2028. Growi...
May 2023
144 pages
Middle East & Africa Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)
US$ 3,000.00
The Middle East & Africa blood plasma derivatives market was valued at US$ 1,402.51 million in 2022 and is projected to reach US$ 2,223.69 million by 2028; it is expected to grow at a CAGR of 8.0% fro...
May 2023
145 pages
North America Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)
US$ 3,000.00
The North America blood plasma derivatives market was valued at US$ 11,821.24 million in 2022 and is projected to reach US$ 20,447.70 million by 2028; it is expected to grow at a CAGR of 9.6% from 202...
May 2023
137 pages
North America Stem Cell Therapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, and Other Stem Cell Therapy), Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Hospitals & Specialty Clinics and Academic & Research Institutes)
US$ 3,000.00
The North America stem cell therapy market was valued at US$ 1,299.39 million in 2022 and is projected to reach US$ 3,582.26 million by 2028; it is expected to grow at a CAGR of 18.4% from 2022 to 202...
May 2023
133 pages
South & Central America Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)
US$ 3,000.00
The South & Central America blood plasma derivatives market was valued at US$ 1,864.04 million in 2022 and is projected to reach US$ 3,067.15 million by 2028; it is expected to grow at a CAGR of 8.7%...
May 2023
137 pages
Organ Preservation Solution Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type [University of Wisconsin Solution (UW), Custodiol HTK, Perfadex, Hypothermosol, and Others], Application (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Others), Organ Type (Kidneys, Liver, Lungs, Heart, and Others), and End User (Organ Transplant Centers, Hospitals, and Specialty Clinics)
US$ 4,550.00
According to our new research study on 'Organ Preservation Solution Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Application, Organ Type, and End User,' the market was valu...
May 2023
211 pages
Genomics Market by Product & Service (Consumables, Instrument, System & Software), Technology (Sequencing, PCR, Microarray), Study Type (Epigenomics, Biomarker Discovery), Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2028
US$ 4,950.00
... at the highest CAGR during the forecast period” Based on product & service, the genomics market is segmented into consumables, systems & software, and services ... major players operating in this market. Research coverage: This report studies the genomics market based on product and service, application, end user ...
April 2023
395 pages
Asia Pacific Enzymatic DNA Synthesis Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Custom DNA Synthesis and DNA Library Synthesis), Application (Synthetic Biology, Genetic Engineering, Therapeutic Antibodies, Vaccine Design, and Others), and End User (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, and Others)
US$ 3,000.00
The Asia Pacific enzymatic DNA synthesis market is expected to grow from US$ 29.18 million in 2022 to US$ 301.49 million by 2028. It is estimated to register a CAGR of 47.6% from 2022 to 2028. Rising...
April 2023
129 pages
Europe Enzymatic DNA Synthesis Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Custom DNA Synthesis and DNA Library Synthesis), Application (Synthetic Biology, Genetic Engineering, Therapeutic Antibodies, Vaccine Design, and Others), and End User (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, and Others)
US$ 3,000.00
The Europe enzymatic DNA synthesis market is expected to grow from US$ 78.55 million in 2022 to US$ 727.79 million by 2028. It is estimated to register a CAGR of 44.9% from 2022 to 2028. Growing Deman...
April 2023
131 pages
Middle East & Africa Enzymatic DNA Synthesis Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Custom DNA Synthesis and DNA Library Synthesis), Application (Synthetic Biology, Genetic Engineering, Therapeutic Antibodies, Vaccine Design, and Others), and End User (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, and Others)
US$ 3,000.00
The Middle East & Africa enzymatic DNA synthesis market is expected to grow from US$ 9.76 million in 2022 to US$ 92.26 million by 2028. It is estimated to register a CAGR of 45.4% from 2022 to 2028. G...
April 2023
116 pages
North America Biosimilars Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Disease Indication (Cancer, Diabetes, Autoimmune Diseases, and Other Diseases), Drug Class (Granulocyte Colony-Stimulating Factors, Human Growth Hormone, Insulin, TNF Blockers & Monoclonal Antibodies, Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others)
US$ 3,000.00
The North America biosimilars market is expected to grow from US$ 7,115.74 million in 2022 to US$ 47,746.80 million by 2028. It is estimated to grow at a CAGR of 37.3% from 2022 to 2028. Increasing Pr...
April 2023
166 pages
North America Enzymatic DNA Synthesis Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Custom DNA Synthesis and DNA Library Synthesis), Application (Synthetic Biology, Genetic Engineering, Therapeutic Antibodies, Vaccine Design, and Others), and End User (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, and Others)
US$ 3,000.00
The North America enzymatic DNA synthesis market is expected to grow from US$ 110.43 million in 2022 to US$ 1,011.32 million by 2028. It is estimated to register a CAGR of 44.6% from 2022 to 2028. Ris...
April 2023
122 pages
South America Biosimilars Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Disease Indication (Cancer, Diabetes, Autoimmune Diseases, and Other Diseases), Drug Class (Granulocyte Colony-Stimulating Factors, Human Growth Hormone, Insulin, TNF Blockers & Monoclonal Antibodies, Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others)
US$ 3,000.00
The South America biosimilars market is expected to grow from US$ 1,394.55 million in 2022 to US$ 8,449.92 million by 2028. It is estimated to grow at a CAGR of 35.0% from 2022 to 2028. Collaborations...
April 2023
147 pages
South & Central America Enzymatic DNA Synthesis Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Custom DNA Synthesis and DNA Library Synthesis), Application (Synthetic Biology, Genetic Engineering, Therapeutic Antibodies, Vaccine Design, and Others), and End User (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, and Others)
US$ 3,000.00
The South & Central America enzymatic DNA synthesis market is expected to grow from US$ 13.04 million in 2022 to US$ 112.02 million by 2028. It is estimated to register a CAGR of 43.1% from 2022 to 20...
April 2023
112 pages
Europe Biosimilars Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Disease Indication (Cancer, Diabetes, Autoimmune Diseases, and Other Diseases), Drug Class (Granulocyte Colony-Stimulating Factors, Human Growth Hormone, Insulin, TNF Blockers & Monoclonal Antibodies, Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others)
US$ 3,000.00
The Europe biosimilars market is expected to grow from US$ 10,188.49 million in 2022 to US$ 56,373.61 million by 2028. It is estimated to grow at a CAGR of 33.0% from 2022 to 2028. Cost Effectiveness...
April 2023
170 pages
Middle East & Africa Biosimilars Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Disease Indication (Cancer, Diabetes, Autoimmune Diseases, and Other Diseases), Drug Class (Granulocyte Colony-Stimulating Factors, Human Growth Hormone, Insulin, TNF Blockers & Monoclonal Antibodies, Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others)
US$ 3,000.00
The Middle East & Africa biosimilars market is expected to grow from US$ 1,190.50 million in 2022 to US$ 6,408.87 million by 2028. It is estimated to grow at a CAGR of 32.4% from 2022 to 2028. Collabo...
April 2023
158 pages
Asia Pacific Biosimilars Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Disease Indication (Cancer, Diabetes, Autoimmune Diseases, and Other Diseases), Drug Class (Granulocyte Colony-Stimulating Factors, Human Growth Hormone, Insulin, TNF Blockers & Monoclonal Antibodies, Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others)
US$ 3,000.00
The Asia Pacific biosimilars market is expected to grow from US$ 3,141.28 million in 2022 to US$ 22,533.11 million by 2028. It is estimated to grow at a CAGR of 38.9% from 2022 to 2028. Patent Expiry...
April 2023
176 pages
Asia-Pacific and Middle East NGS Market: Focus on Offering, Platform, Throughput, Technology Type, Application, End User, and Country Analysis - Analysis and Forecast, 2022-2027
US$ 5,500.00
Asia-Pacific and Middle East NGS Market Industry Overview The Asia-Pacific and Middle East NGS market was valued at $1,055.6 million in 2022 and is anticipated to reach $2,370.7 million by 2027, witne...
April 2023
217 pages
Gene Switch / Molecular Switch Market - Distribution by Application Area (Management of Treatment Related Toxicity, Regulation of Gene Expression and Other Applications), Type of Target Therapy (CAR T Cell Therapy, Gene Therapy and Other Therapies), Type of Payment Model Employed (Upfront Payments and Milestone Payments), and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2023-2035
US$ 4,799.00
The global gene switch / molecular switch market is expected to reach USD 670 million in 2023 anticipated to grow at a CAGR of 11.5% during the forecast period 2023-2035. In recent years, the field of...
April 2023
210 pages
Digital Manufacturing Market for Biologics: Distribution by Type of Technology (Process Analytical Technology, Data Analysis Software, Manufacturing Execution System and Digital Twin), Deployment Options (Cloud-based and On-premises), Type(s) of Biologic(s) Manufactured (Antibodies, Cell Therapies and Gene Therapies, Proteins, Vaccines, and Others), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa): Industry Trends and Global Forecasts, 2023-2035
US$ 4,799.00
The global digital manufacturing market is anticipated to grow at a CAGR of 18% during the forecast period 2023-2035. The pharmaceutical industry has exhibited substantial interest in undergoing digit...
March 2023
254 pages
Aseptic Fill Finish Manufacturing Market by Type of Molecule (Small Molecules and Biologics), Type of Packaging Container Offered (Ampoules, Cartridges, Prefilled Syringe and Vials), Type of Drug Product (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Products), Scale of Operation (Preclinical / Clinical and Commercial), Company Size (Large, Mid-sized and Small), Target Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases Oncological Disorders, and Other Disorders) and Geographical Regions (North America, Europe, Asia Pacific, Middle East and North Africa and Latin America): Industry Trends and Global Forecasts, 2023-2035
US$ 4,799.00
The aseptic fill finish market is expected to reach USD 5.4 billion in 2023 anticipated to grow at a CAGR of 9% during the forecast period 2023-2035. The term 'aseptic fill finish' encapsulates the me...
March 2023
270 pages
Biopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
US$ 4,550.00
The biopharmaceuticals market is expected to grow from US$ 3,29,966.22 million in 2022 to US$ 7,00,873.94 million by 2028; it is expected to grow at a CAGR of 13.4% from 2022 to 2028. Rising applicati...
March 2023
346 pages
Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)
US$ 4,550.00
The blood plasma derivatives market is expected to reach US$ 51,119.24 million by 2028 from US$ 29.886.12 million in 2022; it is estimated to record a CAGR of 9.4% from 2022 to 2028. The rising preval...
March 2023
209 pages
Enzymatic DNA Synthesis Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Custom DNA Synthesis and DNA Library Synthesis), Application (Synthetic Biology, Genetic Engineering, Therapeutic Antibodies, Vaccine Design, and Others), End User (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, and Others), and Technology (SOLA, CRISPR, PCR, and Others)
US$ 4,550.00
The enzymatic DNA synthesis market value is projected to reach US$ 2,244.88 million by 2028 from US$ 240.96 million in 2022; it is estimated to record a CAGR of 45.1% from 2022 to 2028. The rising pre...
March 2023
211 pages
Global Biotech Partnering Terms and Agreements 2018-2023
US$ 3,995.00
SUMMARY Global Biotech Partnering Terms and Agreements 2014 to 2019 report provides a detailed understanding and analysis of how and why companies enter Biotech partnering deals DESCRIPTION Global Biotech Partnering Terms and Agreements 2014 ...
March 2023
3800 pages
Filtration Market (Focus on Biologics Manufacturing) - Distribution by Type of Filtration System (Depth Filtration, Tangential Flow Filtration, Virus Filtration and Other Membrane Filters), Type of Filter (based on use) (Disposable / Single use Filters and Reusable / Multi use Filters), Type of Assembly (Capsules, Cartridges and Others), Company Size (Small, Mid-sized and Large) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2023-2035
US$ 4,799.00
The global filtration market is expected to reach USD 5.1 billion in 2023 anticipated to grow at a CAGR of 10% during the forecast period 2023-2035. The healthcare sector has experienced remarkable ex...
March 2023
165 pages
Biosimilars Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Indication (Cancer, Diabetes, Autoimmune Diseases, and Other Diseases), Drug Class (Granulocyte Colony-Stimulating Factors, Human Growth Hormone, Insulin, TNF Blockers & Monoclonal Antibodies, Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others)
US$ 4,550.00
The biosimilars market was valued at US$ 18,435.89 million in 2021 and is expected to reach US$ 136,069.53 million by 2028; it is estimated to record a CAGR of 34.8% from 2022 to 2028. The biosimilars...
February 2023
217 pages
Biologics Development and Manufacturing Testing: Technologies and Global Markets
US$ 5,500.00
... biological safety testing used for characterization and release of biopharmaceutical, veterinary and medical diagnostics products. BCC Research analyzes each market ... developments. REPORT INCLUDES: An overview of the global market for biological safety testing and related technologies. Analyses of global market ...
February 2023
123 pages
Biobanks Market Size, Share & Trends Analysis Report By Product (LIMS, Biobanking Equipment), By Biospecimen Type (Organs, Stem Cells), By Biobank Type (Real, Virtual), By Service, By Application, And Segment Forecasts, 2023 - 2030
US$ 5,950.00
The global biobanks market size is expected to reach USD 74.54 billion by 2025 at a 4.5% CAGR over the forecast ... cost of equipment, coupled with rapid increase in number of biobanks, is attributive to its leading revenue share The LIMS segment is projected to witness lucrative growth ...
February 2023
180 pages
Mammalian Polyclonal IgG Antibody Market Size, Share & Trends Analysis Report By Type (Mouse, Rabbit), By Product (Cardiac, Metabolic), By Application (Western Blotting, ELISA), By End-user, And Segment Forecasts, 2023 - 2030
US$ 5,950.00
The global mammalian polyclonal IgG antibody market size is expected to reach USD 1.21 billion by 2025 expanding at a CAGR of 5.1%, according to ... presence of target population Few key companies in the global mammalian polyclonal IgG antibody market include Abcam PLC; Bio-Rad Laboratories, Inc.; Thermo Fisher ...
February 2023
180 pages
Stem Cell Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, and Other Stem Cell Therapy), Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Hospitals & Specialty Clinics and Academic & Research Institutes), and Geography
US$ 4,550.00
The stem cell therapy market size is expected to grow from US$ 2,278.49 million in 2022 to US$ 6,206.89 million by 2028. The market is estimated to register a CAGR of 18.2% from 2022 to 2028. The grow...
February 2023
206 pages
Regenerative Medicine Market Size, Share & Trends Analysis Report By Product (Cell-based Immunotherapies, Gene Therapies), By Therapeutic Category, By Region, And Segment Forecasts, 2023 - 2030
US$ 5,950.00
... regenerative medicine market size is expected to reach USD 5.60 billion by 2025, expanding at a CAGR of 11.6% over the forecast period, according to a new report by Grand View Research, Inc. Regenerative medicines ...
February 2023
180 pages
Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Genome Engineering, Bioinformatics), Applications (Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental)- Global Forecast to 2027
US$ 4,950.00
... portfolios offered by key players in the global synthetic biology market. The report analyzes the global synthetic biology market by tool, technology, application, and region. Product and Service ...
February 2023
441 pages
Single-use Bioreactors Market Size, Share & Trends Analysis Report By Product, By Type, By Type Of Cell, By Molecule Type, By Application, By End-use, By Usage Type, By Region, And Segment Forecasts, 2023 - 2030
US$ 5,950.00
This report can be delivered to the clients within 2 Business Days Single-use Bioreactors Market Growth & Trends The global single-use bioreactors market size is expected to reach USD 12.06 billion...
February 2023
160 pages
Europe Membrane Separation Systems Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Technology (Reverse Osmosis, Microfiltration, Ultrafiltration, Nanofiltration, Ion Exchange, and Others), Application (Environmental, Food and Beverages, Healthcare, and Others), and Material [Polyethersulfone (PES), Polysulfone (PSF), Polypropylene (PP), Polyvinylidene Fluoride (PVDF), Polyacrylonitrile (PAN), and Others]
US$ 3,000.00
The Europe membrane separation systems market is expected to grow from US$ 6,449.78 million in 2022 to US$ 10,697.39 million by 2028. It is estimated to record a CAGR of 8.8% from 2022 to 2028. Exten...
January 2023
164 pages
Middle East & Africa Membrane Separation Systems Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Technology (Reverse Osmosis, Microfiltration, Ultrafiltration, Nanofiltration, Ion Exchange, and Others), Application (Environmental, Food and Beverages, Healthcare, and Others), and Material [Polyethersulfone (PES), Polysulfone (PSF), Polypropylene (PP), Polyvinylidene Fluoride (PVDF), Polyacrylonitrile (PAN), and Others]
US$ 3,000.00
The MEA membrane separation systems market is expected to grow from US$ 1,149.43 million in 2022 to US$ 1,836.66 million by 2028. It is estimated to record a CAGR of 8.1% from 2022 to 2028. New Class...
January 2023
149 pages
South America Plant Tissue Culture Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Instruments, Media & Reagents, and Consumables), Application (Plant Research, Agriculture, Forestry & Technical Grade, and Others), and End Users (Greenhouse, Field, and Laboratory)
US$ 3,000.00
The South America plant tissue culture market is expected to grow from US$ 37.17 million in 2022 to US$ 59.91 million by 2028; it is estimated to register a CAGR of 8.3% from 2022 to 2028. Automation...
January 2023
111 pages
North America Plant Tissue Culture Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Instruments, Media & Reagents, and Consumables), Application (Plant Research, Agriculture, Forestry & Technical Grade, and Others), and End Users (Greenhouse, Field, and Laboratory)
US$ 3,000.00
The North America plant tissue culture market is expected to grow from US$ 167.46 million in 2022 to US$ 277.27 million by 2028; it is estimated to record a CAGR of 8.8% from 2022 to 2028. Increasing...
January 2023
109 pages
APAC In Situ Hybridization Market by Products (Consumables, Instruments, Software), Technology (DNA FISH, RNA FISH, PNA FISH, CISH), Application (Cancer, Immunology, Neuroscience, Cytology), End User (Hospital, Pharma, Biotech, CROs) - Forecast to 2027
US$ 4,950.00
The Asia Pacific in situ hybridization market is projected to reach USD 744 million by 2027 from USD 363 million in 2022, at a CAGR of 15.4% during the forecast period. Companion diagnostic products s...
January 2023
154 pages
APAC Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics (IHC, ISH), Spatial Genomics (FISH, Sequencing)), Product (Instruments, Consumables, Software), Application (Drug Discovery), End User (Biotech, CROs) - Forecast to 2027
US$ 4,950.00
The Asia Pacific spatial genomics and transcriptomics market is projected to reach USD 152 million by 2027 from USD 64 million in 2022, at a CAGR of 18.9% during the forecast period. The key factors d...
January 2023
145 pages
4D Bioprinting Market – Distribution by Type of Technology (Extrusion-based Technology, Laser-based Technology, Inkjet-based Technology and Others), Application Area (Biomedical Applications and Others), End-user (Pharmaceutical and Biotechnology Companies, Academic Research and Development and Other End-users) and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa): Industry Trends and Global Forecasts, 2023-2035
US$ 4,799.00
The 4D bioprinting market is expected to reach USD 21 million in 2023 and anticipated to grow at a CAGR of 34% during the forecast period 2019-2030 The emergence of 3D printing has sparked a profound...
January 2023
183 pages
Biologics Fill Finish Manufacturing Market (3rd Edition) by Type of Packaging Containers (Ampoules, Cartridges, Syringes and Vials), Type of Biologics (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Biologics), Scale of Operation (Preclinical / Clinical and Commercial), Company Size (Large, Mid-sized and Small), Key Therapeutic Areas (Autoimmune Disorders, Oncological Disorders, Cardiovascular Disorders, Infectious Diseases and Other Disorders), Geographical Regions (North America, Europe, Asia Pacific, Middle East and North Africa and Latin America): Industry Trends and Global Forecasts, 2022-2035
US$ 4,799.00
The biologics fill finish manufacturing market is expected to reach USD 4 billion by 2022 and is anticipated to grow at a CAGR of 8.4% during the forecast period 2022-2035 The rise of biologics marks...
January 2023
659 pages
